Japan Medical Dynamic Marketing, Inc. (7600) AI Stock Analysis

• Market Cap: ¥14.62B
• Dividend Yield: 2.77%
• Average Volume (3M): 32.85K
• Price to Earnings (P/E): 10.2
• Beta (1Y): 0.54
• Revenue Growth: 8.35%
• EPS Growth: -136.31%
• Country: JP
• Employees: 511
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Devices
• EPS (TTM): -50.93
• Shares Outstanding: 26,475,880
• 10 Day Avg. Volume: 26,560
• 30 Day Avg. Volume: 32,850
• PEG Ratio: 0.24
• Price to Book (P/B): 0.60
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥561.00
• Price Target Upside: -0.18% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 56 Neutral
• Price Target: ¥573.00 ▲(1.96%Upside)

The most significant factor influencing the overall score is the financial performance, where negative net income and free cash flow issues are major concerns. Technical analysis indicates a bearish trend, further contributing to a lower score. The valuation is impacted negatively due to the negative P/E ratio, marking the stock as unattractive despite a moderate dividend yield.

Japan Medical Dynamic Marketing, Inc. Business Overview & Revenue Model

Company Description

Japan Medical Dynamic Marketing, Inc. (7600) is a Japan-based company primarily engaged in the medical device sector. The company focuses on the development, manufacturing, and distribution of orthopedic implants and surgical instruments. Its core products include spinal systems, trauma devices, and joint-related solutions, catering to healthcare providers and medical institutions both domestically and internationally.

How the Company Makes Money

Japan Medical Dynamic Marketing, Inc. generates revenue through the sale of its medical devices and instruments to hospitals, clinics, and healthcare facilities. The company earns money by leveraging its expertise in the medical field to offer innovative and effective solutions for orthopedic and surgical needs. Key revenue streams include direct sales of products, partnerships with healthcare providers, and potentially ongoing service or maintenance contracts for its equipment. Additionally, strategic collaborations with other medical companies and participation in government healthcare initiatives may also contribute to its earnings.

Japan Medical Dynamic Marketing, Inc. Financial Statement Overview

Summary

The company shows stable revenue growth but faces profitability challenges due to negative net income in 2025. A robust balance sheet with low leverage is a positive factor, but negative free cash flow indicates cash management issues.

Income Statement

The company experienced a moderate revenue growth rate over recent years, with a notable increase from 2024 to 2025. However, the net profit margin turned negative in 2025, indicating profitability challenges. Gross profit margins have remained relatively stable, but declining EBIT and EBITDA margins suggest rising operational costs.

Balance Sheet

The balance sheet shows a strong equity base with a healthy equity ratio, demonstrating financial stability. The debt-to-equity ratio is relatively low, indicating conservative leverage. However, a decrease in stockholders' equity in 2025 could be a concern if it continues.

Cash Flow

Free cash flow has fluctuated, turning negative in 2025, which might impact liquidity. The operating cash flow to net income ratio shows adequate cash conversion, but the negative free cash flow raises concerns about the company's ability to fund operations and growth without external financing.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	25.11B	23.18B	21.31B	19.19B	16.74B
Gross Profit	14.21B	14.76B	13.99B	12.99B	11.42B
EBITDA	1.40B	3.27B	3.35B	4.21B	3.47B
Net Income	-461.80M	1.27B	1.42B	2.14B	1.66B
Balance Sheet
Total Assets	33.67B	31.49B	29.43B	27.34B	25.19B
Cash, Cash Equivalents and Short-Term Investments	3.18B	2.32B	2.80B	2.59B	2.47B
Total Debt	3.29B	1.49B	1.87B	1.85B	3.09B
Total Liabilities	8.93B	5.88B	6.14B	5.85B	6.48B
Stockholders Equity	24.68B	25.51B	23.16B	21.39B	18.63B
Cash Flow
Free Cash Flow	-504.10M	302.45M	870.67M	1.53B	1.23B
Operating Cash Flow	1.05B	2.10B	2.19B	3.11B	2.60B
Investing Cash Flow	-1.67B	-1.80B	-1.48B	-1.75B	-1.35B
Financing Cash Flow	1.49B	-840.71M	-514.78M	-1.29B	-1.31B

Japan Medical Dynamic Marketing, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 562.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7600, the sentiment is Negative. The current price of 562 is above the 20-day moving average (MA) of 557.65, above the 50-day MA of 551.88, and below the 200-day MA of 588.59, indicating a neutral trend. The MACD of 0.28 indicates Positive momentum. The RSI at 49.28 is Neutral, neither overbought nor oversold. The STOCH value of 58.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7600.

Japan Medical Dynamic Marketing, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7963	81 Outperform	¥8.61B	10.25		2.03%	11.24%	53.32%
5187	78 Outperform	¥8.67B	8.44		3.57%	4.59%	1130.01%
7792	77 Outperform	¥12.87B	10.11		2.11%	13.54%	78.47%
6678	74 Outperform	¥15.64B	12.67		3.71%	5.92%	8.59%
Sector *	65 Neutral	¥345.70B	11.08	-2.99%	2.56%	11.77%	-10.16%
7600	56 Neutral	¥14.62B	10.23		2.77%	8.35%	-136.31%
7777	54 Neutral	¥22.06B	―	-184.59%	―	78.18%	35.77%

Japan Medical Dynamic Marketing, Inc. Corporate Events

Japan Medical Dynamic Marketing Affirms Independence Amid Mitsui Chemicals Alliance

Japan Medical Dynamic Marketing, Inc. announced its relationship with Mitsui Chemicals, Inc., highlighting a capital and business alliance aimed at expanding their operations in the medical device field. Despite Mitsui Chemicals’ significant voting rights, Japan Medical Dynamic Marketing maintains operational independence, ensuring no restrictions on its business activities, which supports its strategic growth and industry positioning.

Japan Medical Dynamic Marketing Reports Financial Discrepancy for Fiscal Year 2025

Japan Medical Dynamic Marketing, Inc. reported a discrepancy between its forecasted and actual financial results for the fiscal year ending March 2025. The company experienced a larger than expected net loss due to the decision not to recognize deferred tax assets related to litigation settlement expenses. However, it anticipates recognizing these tax effects in the next fiscal year, potentially improving future financial outcomes.

Japan Medical Dynamic Marketing Reports Fiscal Year 2025 Financial Results

Japan Medical Dynamic Marketing, Inc. reported its financial results for the fiscal year ending March 2025, showing an 8.4% increase in net sales to ¥25,114 million. However, the company faced a decline in operating and ordinary profits, and a net loss attributable to owners of the parent. The capital adequacy ratio decreased to 73.3%, and cash flow from operating activities also declined. The company plans to increase its annual dividend to ¥15.00 per share, reflecting a cautious yet optimistic outlook for the upcoming fiscal year.